Filing Details
- Accession Number:
- 0001387131-14-000518
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-13 19:10:28
- Reporting Period:
- 2014-02-11
- Filing Date:
- 2014-02-13
- Accepted Time:
- 2014-02-13 19:10:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532233 | Brian Bernick | 6800 Broken Sound Parkway Nw, 3Rd Floor Boca Raton FL 33487 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-02-11 | 15,625 | $6.27 | 7,472,892 | No | 4 | S | Indirect | BF Investments Enterprises, LLC |
| Common Stock | Disposition | 2014-02-12 | 15,625 | $6.05 | 7,457,267 | No | 4 | S | Indirect | BF Investments Enterprises, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | BF Investments Enterprises, LLC |
| No | 4 | S | Indirect | BF Investments Enterprises, LLC |
Footnotes
- The shares were sold pursuant to a 10b5-1 Sales Plan dated December 9, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.16 to $6.32, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.25, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
